Does TOFACITINIB Cause Epistaxis? 372 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 372 reports of Epistaxis have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.2% of all adverse event reports for TOFACITINIB.
372
Reports of Epistaxis with TOFACITINIB
0.2%
of all TOFACITINIB reports
4
Deaths
53
Hospitalizations
How Dangerous Is Epistaxis From TOFACITINIB?
Of the 372 reports, 4 (1.1%) resulted in death, 53 (14.2%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Epistaxis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 372 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Epistaxis?
RIVAROXABAN (5,629)
ASPIRIN (3,214)
APIXABAN (2,831)
FLUTICASONE (1,745)
TREPROSTINIL (1,726)
CLOPIDOGREL BISULFATE (1,560)
BEVACIZUMAB (1,542)
WARFARIN (1,498)
PALBOCICLIB (1,280)
ADALIMUMAB (1,243)
Which TOFACITINIB Alternatives Have Lower Epistaxis Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN